Stop excluding male patients
Male breast cancer is a rare disease, accounting for less than 1% of all breast cancers worldwide but how does their disease differ from breast cancers in women? Fatima Cardoso explains why men should be [more]
March 2010
Alain Fourquet: taking multidisciplinarity one step further
Fourquet will become the first radio-oncologist to chair Europe’s major breast cancer conference, EBCC 7, in March. Here he argues that radio-oncologists need to be involved in the design stage of trials. Download full article
Neutropenia in cancer patients: risk factors and management
Neutropenia poses a serious threat to patients on chemotherapy – exposes them to infection, leads to delays in treatment and reductions in dose intensity. Awareness of the risks and prompt action are essential. Download full [more]
MRI for breast cancer: who benefits, who is harmed?
When a woman is diagnosed with breast cancer, and a technique exists that could identify additional lesions in the same or the opposite breast, what possible reason could there be for not using it? Download [more]